Article
Licensed
Unlicensed
Requires Authentication
Congress Calendar
Published/Copyright:
October 6, 2017
Published Online: 2017-10-6
Published in Print: 2017-10-26
©2017 Walter de Gruyter GmbH, Berlin/Boston
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Frontmatter
- Editorial
- Preeclampsia and intrauterine growth restriction: placental disorders still not fully understood
- Review article
- Hepar uterinum: a history of ideas on fetal nutrition
- Original articles
- Twin pregnancy in women above the age of 45 years: maternal and neonatal outcomes
- Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction
- Maternal venous SHARP1 levels in preeclampsia
- Second-trimester maternal serum markers in the prediction of preeclampsia
- Pregnancy outcomes regarding maternal serum AFP value in second trimester screening
- Quantification of mechanical dyssynchrony in growth restricted fetuses and normal controls using speckle tracking echocardiography (STE)
- Serum cholesterol acceptor capacity in intrauterine growth restricted fetuses
- Antithrombin improves the maternal and neonatal outcomes but not the angiogenic factors in extremely growth-restricted fetuses at <28 weeks of gestation
- Simple approach based on maternal characteristics and mean arterial pressure for the prediction of preeclampsia in the first trimester of pregnancy
- Fetal death: an extreme manifestation of maternal anti-fetal rejection
- Intrauterine growth restriction and placental gene expression in severe preeclampsia, comparing early-onset and late-onset forms
- The relationship between maternal and umbilical cord adropin levels with the presence and severity of preeclampsia
- Expression of placental regulatory genes is associated with fetal growth
- Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks’ pregnancy in normotensive women
- A one year review of eclampsia in an Ethiopian Tertiary Care Center (Saint Paul’s Hospital Millennium Medical College, SPHMMC)
- Congress Calendar
- Congress Calendar
Articles in the same Issue
- Frontmatter
- Editorial
- Preeclampsia and intrauterine growth restriction: placental disorders still not fully understood
- Review article
- Hepar uterinum: a history of ideas on fetal nutrition
- Original articles
- Twin pregnancy in women above the age of 45 years: maternal and neonatal outcomes
- Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction
- Maternal venous SHARP1 levels in preeclampsia
- Second-trimester maternal serum markers in the prediction of preeclampsia
- Pregnancy outcomes regarding maternal serum AFP value in second trimester screening
- Quantification of mechanical dyssynchrony in growth restricted fetuses and normal controls using speckle tracking echocardiography (STE)
- Serum cholesterol acceptor capacity in intrauterine growth restricted fetuses
- Antithrombin improves the maternal and neonatal outcomes but not the angiogenic factors in extremely growth-restricted fetuses at <28 weeks of gestation
- Simple approach based on maternal characteristics and mean arterial pressure for the prediction of preeclampsia in the first trimester of pregnancy
- Fetal death: an extreme manifestation of maternal anti-fetal rejection
- Intrauterine growth restriction and placental gene expression in severe preeclampsia, comparing early-onset and late-onset forms
- The relationship between maternal and umbilical cord adropin levels with the presence and severity of preeclampsia
- Expression of placental regulatory genes is associated with fetal growth
- Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks’ pregnancy in normotensive women
- A one year review of eclampsia in an Ethiopian Tertiary Care Center (Saint Paul’s Hospital Millennium Medical College, SPHMMC)
- Congress Calendar
- Congress Calendar